HC nod to Natco for generic Risdiplam

In a setback to Swiss pharma major Roche, the Delhi High Court has refused to restrain local drugmaker Natco Pharma from selling a generic version of lifesaving drug Risdiplam in India, upholding a March single-judge order.

- Krishna Yadav & Jessica Jani

The written order had not been released by press time.

A division bench of justices C. Hari Shankar and Ajay Digpaul upheld the March 2023 single-judge bench order that had denied Roche an injunction against Natco Pharma. The single bench had cited public interest, noting that wider access to an affordable drug would benefit patients who otherwise cannot afford treatment.